UPCOMING SESSIONS in ET
Wed, May 6, 2026
10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health Sarah C Paciulli Click To Register
UPCOMING SESSIONS in ET
Wed, May 6, 2026 · 10:00 – 11:00 PM UTC
Webinar: Emerging Roles of TTR in ATTR-CM and Your Overall Health
Sarah C Paciulli
Click To Register
View all sessions

NICE (UK) positive for Beyonttra (acoramidis) for treating transthyretin amyloidosis with cardiomyopathy – Bayer

Published: Apr 02, 2026
Category
News
Source
Medical Update Online

NICE(UK): Acoramidis can be used, within its marketing authorisation, as an option to treat wild-type or hereditary transthyretin amyloidosis with cardiomyopathy in adults.

Acoramidis can only be used if the company provides it according to the commercial arrangement.

News Url
Read More